Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss after childbirth is more common in women who have had multiple births, cesarean deliveries, significant weight gain, and full-term pregnancies.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Two specific genetic markers increase the risk of hair loss in Asian populations.

The author was scammed by a marketing company and discussed a man scammed by a clinic that provided poor hair transplants, leading to bad results and scarring.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

Finasteride effectively treats male hair loss, increasing length and thickness.

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.

ILC1-like cells may contribute to hair loss in alopecia areata.

Laser therapy shows promise for hair loss but lacks strong evidence due to limited studies.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Low-dose isotretinoin and erythromycin effectively treated hair loss in two young sisters.

The combined treatment for hair loss is effective, easy to use, and has mild side effects.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

Nano-sized molybdenum may help treat hair loss and works well with minoxidil.

A mouse model was created to study hair loss similar to humans.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Low-dose oral minoxidil improves hair growth in male hair loss.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Short telomeres may cause symptoms like hair loss and osteoporosis, offering insights into aging.

A different gene near the hairless gene on chromosome 8p21 causes a rare hair loss condition in a German family.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

PRP therapy and minoxidil combo works best for male hair loss.

A specific group of skin stem cells was found to help maintain hair follicle cells.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

A new model uses specific blood markers to predict if children's hair loss will return.

Ferritin and vitamin B12 deficiencies are common causes of hair loss in women aged 18-45.